Trial · NCT07911137
Effect of Oxybutynin on Opioid Use After Urologic Surgery in Children
NCT07911137, Phase 4, Not yet recruiting, University of Calgary
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Oxybutynin on Opioid Use After Urologic Surgery in Children. Trials, record NCT07911137. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911137
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Oxybutynin on Opioid Use After Urologic Surgery in Children
- NCT number
- NCT07911137
- Status
- Not yet recruiting
- Phases
- Phase 4
- Enrollment
- 200 participants, estimated
- Lead sponsor
- University of Calgary
- Conditions
- Ureteropelvic Junction Obstruction, Hypospadias
- Interventions
- Oxybutynin, Placebo
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total Cumulative Postoperative Opioid Consumption (MME/kg) | From the end of surgery through 6 hours postoperatively | Total cumulative morphine milligram equivalents per kilogram (MME/kg) administered within 6 hours after surgery |
| Secondary | Proportion of Participants Receiving Postoperative Opioids | From the end of surgery through 6 hours postoperatively | Whether any opioid medication was administered within 6 hours after surgery (yes/no) |
| Secondary | Postoperative Pain Scores (NRS/FLACC) | At 15 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, and 6 hours following postoperative removal of the laryngeal mask airway or endotracheal tube | Pain assessed using age-appropriate validated scales: the Numeric Rating Scale (NRS; 0-10) or the Face, Legs, Activity, Cry, Consolability (FLACC; 0-10) scale. Higher scores indicate greater pain. |
| Secondary | Proportion of Participants Receiving Postoperative Rescue Oxybutynin | From the end of surgery through 6 hours postoperatively | Whether oxybutynin was administered as needed (PRN) within 6 hours after surgery (yes/no). |
| Secondary | Total Cumulative Postoperative Oxybutynin Consumption (mg/kg) | From the end of surgery through 6 hours postoperatively | Total cumulative dose of oxybutynin administered per kilogram of body weight during the first 6 hours after surgery. |
| Secondary | Incidence of Adverse Events | From preoperative study medication administration through postoperative discharge | Occurrence of adverse events, including dry mouth, flushing, tachycardia, agitation, sedation, and urinary retention. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911137
GET https://conductscience.org/api/trials/v1/NCT07911137/registered